A recent article from mobihealthnews.com describes how technology is helping streamline clinical trials by bridging communication between investigators, pharmaceutical companies and participants. Communication between companies and third party investigators is often a...
A recent post from MedPage Today describes the newly published FDA draft guidance entitled “Enrichment Strategies for Clinical Trials to Support Approval of Human Drugs and Biological Products” that will potentially improve the speed of drug development. The guidance...
Ken Getz, assistant professor at Tufts Center for the Study of Drug Development (CSDD), reports that oftentimes procedures performed in the last drug development stages are in order to find “supplementary, secondary, tertiary, and exploratory endpoints.”...
On October 14, the 7th Annual Site Solutions Summit announced the formation of a new association focusing on the needs and challenges of the research site. President of The Society for Clinical Research Sites (SCRS), Christine Pierre is aiming to “provide...
In a recent article by Outsourcing-Pharma, Harvard Medical School scientists from Beth Israel Deaconess Medical Center (BIDMC) claim to have identified genetic differences between people who respond to placebos during trials and those who do not. Only 122 of the 262...
The Coalition For Accelerating Standards and Therapies (CFAST) was introduced at the CDISC International Interchange in Baltimore October 22-26. By congregating experts from each industry, data standards are expected to be maintained and developed. The coalition...